CEMDC - Cooperative European Medicines Development Course

Module II: »Non-clinical, pharmaceutical and early clinical development«

November 30th-December 3rd, 2017

Module 2 of Cooperative European Medicines Development Course (CEMDC) is an integral part of the IMI project Pharmaceutical Medicine Training Program. The CEMDC involves 10 participating European universities, including University of Ljubljana, Faculty of Pharmacy and provides a post-graduate education covering the entire process from drug discovery through all steps of medicines development up to the market.

CEMDC Module 2 is intensive 4-day program with lectures devoted to steps in the pharmaceutical development of a drug substance and an efficient, safe and high quality synthetic or biological/biosimilar drug product. The main focus of the programme is given on selection and predictive value of the non-clinical tests (pharmacology, toxicology studies: genotoxicity, carcinogenicity, reproduction toxicity) and their integration into overall drug development plan.  The program encourages active involvement of the students in problem solving discussions during the contact sessions.

Audience and requirements

The target student population are professionals with medical, pharmaceutical or MSc (or equivalent) degree in natural and life sciences.

Official language



Tuition Fee

800 EUR
The tuition fee covers the lectures, course material (paper and electronic version), as well as coffee breaks, lunch and a “welcome dinner”.

How to apply

For admission, students must submit a copy of their degree and a CV describing their professional experience to the CEMDC office OR to the local organizing committee.


After the successful completion of the written examination, the module certificate will be issued by the respective Module-organizing University and will be accepted by the Coordinating University.